申请人:Schering Corporation
公开号:US05538986A1
公开(公告)日:1996-07-23
Disclosed are compounds of Formula I: ##STR1## or a pharmaceutically acceptable salt or solvate thereof, wherein: R.sup.3 is alkyl, alkenyl, alkynyl, aryl, alkaryl, aralkyl, cycloalkyl, acyloxymethyl, alkoxy, alkoxymethyl, or alkyl substituted with cycloalkyl; R.sup.4 is H, alkyl, alkenyl, alkoxy, or --OH. Also disclosed are pharmaceutical compositions containing compounds of Formula I, methods for inhibiting tumor necrosis factor-.alpha. and methods for treating septic shock, inflammation, or allergic disease by administering a compound of Formula I.
本发明涉及公式I的化合物:##STR1##或其药学上可接受的盐或溶剂,其中:R.sup.3是烷基,烯基,炔基,芳基,烷芳基,芳基烷基,环烷基,酰氧甲基,烷氧基,烷氧甲基,或被环烷基取代的烷基;R.sup.4是H,烷基,烯基,烷氧基或-OH。本发明还涉及含有公式I化合物的制药组合物,通过给予公式I化合物来抑制肿瘤坏死因子α,以及治疗感染性休克,炎症或过敏疾病的方法。